ACTIVATION OF THE STAT3 ACUTE-PHASE RESPONSE FACTOR TRANSCRIPTION FACTOR BY INTERLEUKIN-5

被引:64
|
作者
CALDENHOVEN, E [1 ]
VANDIJK, T [1 ]
RAAIJMAKERS, JAM [1 ]
LAMMERS, JWJ [1 ]
KOENDERMAN, L [1 ]
DEGROOT, RP [1 ]
机构
[1] UNIV UTRECHT HOSP,DEPT PULM DIS,3584 CX UTRECHT,NETHERLANDS
关键词
D O I
10.1074/jbc.270.43.25778
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The receptor for interleukin-5 (IL-5R) is composed of a unique alpha chain (IL-5R alpha) expressed on eosinophils and basophils, associated with a beta c subunit, which is shared by the receptors for IL-S and granulocyte macrophage-colony stimulating factor. One of the molecular events activated via the IL-BR is the JAK/STAT signaling pathway. Recent reports have shown that IL-5 induces tyrosine phosphorylation of JAK2 followed by the subsequent cell type-specific activation of either STAT1 alpha or STAT5. To identify additional STAT proteins activated by IL-5, we co-transfected the IL-5R with STAT cDNAs in COS cells. We found that IL-5 induces binding of STAT3 to the intercellular adhesion molecule-1 pIRE, and activates STAT3-dependent transcription. Moreover, endogenous STAT3 was tyrosine phosphorylated and activated in human IL-5-stimulated BaF3 cells ectopically expressing the human IL-5R (BaF3/IL5R). These data imply that multiple STAT proteins are involved in gene regulation by IL-S in a cell type-specific manner. We further demonstrate using C-terminal truncations of the alpha and beta c subunits of the IL-5R that the membrane-proximal regions of both subunits are required for STAT activation. Interestingly, a beta c receptor mutant lacking intracellular tyrosine residues is able to mediate STAT3 activation, suggesting that tyrosine phosphorylation of the beta c receptor is not essential for STAT3 activation.
引用
收藏
页码:25778 / 25784
页数:7
相关论文
共 50 条
  • [31] Sequestration of the Transcription Factor STAT3 by the Molecular Chaperone CCT: A Potential Mechanism for Modulation of STAT3 Phosphorylation
    Vallin, Josefine
    Cordoba-Beldad, Carmen M.
    Grantham, Julie
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (13)
  • [32] Epigenetic regulation of transcription factor STAT3 activity in cancer cells
    Sehgal, Pravin B.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (08): : 373 - 377
  • [33] Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
    Lee, David S.
    O'Keefe, Rachel A.
    Ha, Patrick K.
    Grandis, Jennifer R.
    Johnson, Daniel E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [34] Signal Transduction and Activation of Transcription Factor 3 (STAT3) Mediates Neonate Hypoxic Ischaemic Brain Injury
    Rocha-Ferreira, Eridan
    Thei, Laura
    Peebles, Donald
    Behrens, Axel
    Akira, Shizuo
    Raivich, Gennadij
    Hristova, Mariya
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 372A - 372A
  • [35] Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
    Xiong, Ailian
    Yang, Zhengduo
    Shen, Yicheng
    Zhou, Jia
    Shen, Qiang
    CANCERS, 2014, 6 (02) : 926 - 957
  • [36] STAT3 transcription factor as target for anti-cancer therapy
    Aliaa M. Mohassab
    Heba A. Hassan
    Dalia Abdelhamid
    Mohamed Abdel-Aziz
    Pharmacological Reports, 2020, 72 : 1101 - 1124
  • [37] The regulatory relationship between transcription factor STAT3 and noncoding RNA
    Siyi Liu
    Wentao Li
    Lin Liang
    Yanhong Zhou
    Yanling Li
    Cellular & Molecular Biology Letters, 29
  • [38] Transcription factor Stat3 promotes metastatic progression of prostate cancer
    Gu, Lei
    Abdulghani, Junaid
    Dagvadorj, Ayush
    Lutz, Jacqueline
    Bonuccelli, Gloria
    Lisanti, Michael P.
    Zellweger, Tobias
    Alanen, Kalle
    Mirtti, Tuomas
    Visakorpi, Tapio
    Bubendorf, Lukas
    Nevalainen, Marja T.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 392 - 392
  • [39] STAT3 transcription factor as target for anti-cancer therapy
    Mohassab, Aliaa M.
    Hassan, Heba A.
    Abdelhamid, Dalia
    Abdel-Aziz, Mohamed
    PHARMACOLOGICAL REPORTS, 2020, 72 (05) : 1101 - 1124
  • [40] Transcription Factor STAT3 As a Prognostic Marker and Therapeutic Target in Cancer
    Frank, David A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (36) : 4560 - 4561